Malignant Brain Glioma — Trials

Malignant Brain Glioma — Trials · CancerIndex

Clinical trials

Registered studies

187 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 75
Recruiting: 43
Ph III recruiting: 1
Growth YoY: —
Industry share: 12%
Top sponsor: Nationwide Children's Hospital
Termination share: 40%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (32)

clinicaltrialsPublishedShowing 51–57 of 57 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01393912	PDGFR Inhibitor Crenolanib in Children/Young Adults With Diffuse Intrinsic Pontine Glioma or Recurrent High-Grade Glioma	completed	Phase 1	55	St. Jude Children's Research HospitalOTHER	1	Apr 26, 2017	clinicaltrials
NCT00326664	AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors	completed	Phase 1	55	National Cancer Institute (NCI)NIH	1	Mar 7, 2016	clinicaltrials